Interstitial Lung Disease (ILD) 101
Activity Dates: May 5, 2026 – May 5, 2027
Missed or delayed diagnoses of interstitial lung disease (ILD) remain a critical challenge in clinical practice—are you recognizing the early signs?
Join expert pulmonologists and ILD specialists Josh Solomon and Jeff Swigris for a practical primer designed to improve your clinical approach to ILD. In this engaging discussion, the hosts break down key elements of ILD pathophysiology, highlight when to suspect ILD, and reinforce the importance of including ILD in your differential diagnosis in patients presenting with unexplained shortness of breath.
Through real-world insights, the hosts will share best practices for conducting a thorough history and diagnostic evaluation, along with a concise overview of the evolving treatment landscape. Walk away with actionable strategies to improve early identification and optimize care for patients with ILD.
Learning Objectives
- Describe the pathophysiology and classification of ILD
- Recognize signs, symptoms, and risk factors for ILD and conduct a comprehensive evaluation for patients with suspected ILD
- Describe basic immunomodulatory and anti-fibrotic treatment pathways for ILD
Joshua J. Solomon, MD
Director, Interstitial Lung Disease
Program Professor of Medicine
Section of Critical Care Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO
Jeff Swigris, DO, MS
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO
Conflicts of Interest Disclosure Policy
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties.
All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Faculty Disclosures
Joshua J. Solomon, MD has no relevant financial relationships to report.
Jeff Swigris DO, MS reports the following relevant financial relationships:
Advisory Board:
Gossamer
Boehringer Ingelheim
United Therapeutics
Consultant:
Tvardi
BristolMyersSquibb
GlaxoSmithKline
AbbVie
Puretech
Planner and Reviewer Disclosures
Meghan Brenner, MA has no relevant financial relationships to disclose.
Barbara Goldstein, MD, MMSc has no relevant financial relationships to disclose.
Lauren Gremillion, MBA has no relevant financial relationships to disclose.
Andrea Harshman, MHA, CHCP has no relevant financial relationships to disclose.
Mike Mohning, MD reports the following relevant financial relationships:
Investigator: BristolMyersSquibb
Joshua J. Solomon, MD has no relevant financial relationships to report.
Jeff Swigris DO, MS reports the following relevant financial relationships:
Advisory Board:
Gossamer
Boehringer Ingelheim
United Therapeutics
Consultant:
Tvardi
BristolMyersSquibb
GlaxoSmithKline
AbbVie
Puretech
Unlabeled and Investigational Usage
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.
Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.
Disclaimer Statement
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Privacy Policy
The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME). We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.
If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities. https://www.nationaljewish.org/education/pro-ed/policies
CME Questions?
Contact ProEd@NJHealth.org with any questions about the accreditation of this program.
To claim credit for this episode:
- Review the accreditation and disclosure information below
- Listen to the podcast
- Complete the evaluation and credit attestation here: https://redcap.njhealth.org/redcap/surveys/?s=WHDD9443F9FYP8JW
- Your CME certificate will be available for download
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
National Jewish Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.